Failure to Provide Timely End‑of‑Life Pain and Anxiety Management for a Hospice Resident
Summary
The deficiency involves the facility’s failure to provide timely and appropriate end‑of‑life pain and symptom management for a hospice resident in accordance with physician orders and professional standards of practice. The resident was admitted with multiple chronic conditions, including COPD and CHF, and had severe cognitive impairment, requiring moderate to maximum assistance with ADLs. A provider note documented that the resident had recently presented with fever, shortness of breath, hypoxia, lethargy, and crackles throughout the lungs, and that the family’s and resident’s primary goal of care was comfort. The provider discussed hospice with the family, obtained consent for PRN morphine, lorazepam, and atropine drops for comfort, and sent a hospice referral, with the expectation that hospice would assess the resident that evening. Physician orders were entered for lorazepam intensol 0.25 mL every 4 hours PRN for anxiety/agitation and morphine 0.25 mL every 4 hours PRN for pain/shortness of breath early in the afternoon. A hospice RN assessed the resident later that day and documented that the resident was actively dying, with abnormal vital signs, severe pain (pain score 7/10), moaning, labored breathing, hyperventilation episodes, loud moaning or groaning, crying, and inability to be consoled, as well as agitation, disorientation, lethargy, and restlessness attributed to terminal agitation. The hospice RN noted that an order for sublingual morphine had been written earlier in the day but that the medication had not yet arrived from the pharmacy, and that the unit LPN was calling to obtain an override for needed medications. The hospice RN documented that current pain management was not effective and that they were awaiting morphine from the pharmacy. Medication administration records showed that morphine was not administered until 6:39 PM, approximately four and a half hours after it was ordered and about two hours after the hospice nurse’s assessment documenting severe pain. Lorazepam intensol was not administered until 10:40 PM, approximately nine hours after it was ordered and about six and a half hours after the hospice nurse’s assessment documenting anxiety and terminal agitation. Review of the Omnicell and the emergency E‑Kit showed that morphine and lorazepam intensol were available in the facility and could have been administered earlier. In interviews, the hospice nurse reported that the resident had periods of extreme anxiety and agitation and that the LPN stated she was waiting for a code from the pharmacy before administering morphine. The LPN who cared for the resident during the 3 PM–11 PM shift stated that the resident was sweaty, warm, reaching out for people’s hands, and had arthritis pain, and that she did not feel the resident needed morphine, so she waited to get a code from the pharmacy and administered it later in the evening; she also stated she did not think about the availability of lorazepam intensol in the E‑Kit. The DON acknowledged that the hospice nurse is not employed by the facility and that the facility nurse is responsible for assessing the resident and administering PRN medications, and could not provide evidence that the resident received treatment and care in accordance with professional standards of practice for end‑of‑life medications. Additionally, earlier in the resident’s course, a progress note documented that hospice services had been discussed with the family and that an informational consult in Spanish was requested, with the writer indicating an intent to contact hospice agencies to advocate for that request. Record review did not show evidence that the facility contacted a hospice agency to facilitate the requested informational consultation in Spanish at that time. The hospice agency’s director later reported that the agency did not receive a referral for the resident prior to the date the resident was ultimately admitted to hospice. A family member complainant reported that on the afternoon before the resident’s death there was a delay in providing the ordered morphine and lorazepam, that the resident appeared to be in agonizing pain and anxiety, and that the resident’s feet were hanging off the bed when the family member entered the room. The facility’s failure to use available medications from the Omnicell and E‑Kit and to administer ordered morphine and lorazepam in a timely manner, despite clear signs of severe pain and terminal agitation and the established comfort‑focused goals of care, led to unmanaged pain, terminal agitation, and psychosocial distress during the resident’s final hours of life.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release June 24, 2026) and official state health department websites — never guesswork.
Trusted by long-term care providers and associations.



